The TGA is conducting a public consultation, closing Friday 23 February 2024, on the TGA’s proposed increase to fees and charges for the 2024-25 financial year by a total of 6.71% for medicines and 6.30% for manufacturing licenses.
This member alert provides further information on the TGA Fees and Charges Proposal 2024-25, which describes the reasons for the proposed fee increases, including an increase of the indexation factor by 4.7% and the proposal to apply additional percentage increases on fees and charges relating to digital transformation costs among others, and additional information about TGA cost-recovery framework and public interest activities. It also includes information on a future major review of fees and charges.
The TGA have stated they prefer consolidated industry feedback through representative peak bodies such as CMA, so that the overall industry view can also be considered before finalising next financial year's fees and charges. CMA is developing a position based on knowledge of TGA regulatory activities and performance, and Committee and member feedback.
Members may provide any feedback to the consultation to CMA by Mon 19 Feb2024 via email@example.com and respond to the public consultation independently based on the details in this alert.